Maynard Um
-
-
-
-
-
-
-
AN2 Therapeutics receives FDA clearance for M. abscessus lung disease trial
-
-
-
-
-
-
-
AN2 Therapeutics (ANTX) PT Lowered to $2 at Citizens JMP
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on AN2 Therapeutics (ANTX)
-
-
-
-
-
-
-
Evercore ISI Downgrades AN2 Therapeutics (ANTX) to Underperform
-
433,904 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

